Jump to content

Rifampicin/isoniazid/pyrazinamide

Ɛfi Wikipedia

Rifampicin/isoniazid/pyrazinamide,a wɔsan frɛ no rifampon/isoniazid/pyrazinamide,a ɛnam Rifater so na wɔtɔn no,yɛ aduro a wɔde hwɛ nsamanwa. Ɛyɛ aduro a wɔaka rifampicin, isoniazid, ne pyrazinamide abom.Wɔtumi de ɛno nko ara sa yareɛ anaa sɛ wɔde nnuro binom a ɛtumi nsamanwa ka ko.Wɔde fa anomu.[1]

[sesa]

Yareɛ A Wɔde Sa

[sesa]

Anidasoɔ a ɛwom sɛ wɔaka nnuro yi abom ne sɛ nnipa bɛkɔ so anom nnuro mmiɛnsa no nyinaa. Bio,sɛ nnipa werɛ fi sɛ wɔbɛnom aduro no mu baako anaa mmienu a,wɔrentumi nya aduro no nkaeɛ no mu ahoɔden.

Asetena Ne Amammerɛ

[sesa]

Aventis na wɔyɛeɛ

Hwɛ Nso

[sesa]
  • Nsamanwa ayarehwɛ
  • Rifampicin + isoniazid + ethambutol

Beaeɛ A Menyaa Mmoa Firiiɛ

[sesa]
  1. World Health Organization, Marc C Stuart, Maria Kouimtzi, Suzanne Hill (2009), WHO model formulary 2008 / editors: Marc C. Stuart, Maria Kouimtzi, Suzanne R. Hill (in English), p. 634, retrieved 2024-08-25{{citation}}: CS1 maint: multiple names: authors list (link)